New Gene Therapy Technique Results In Efficient Gene Delivery

June 09, 1998

BOSTON, Mass., June 5--Viruses are normally all together too good at entering our cells. But when scientists alter them to carry desirable genes for genetic therapy, they usually have difficulty getting into the cells where their cargo is needed. Harvard Medical School researchers seem to have overcome this obstacle by building these weighty, less pugnacious viruses a bridge.

The new technique links the virus and target cells by a bridge consisting of two proteins?the growth factor EGF and the receptor for a protein found on the avian leukosis virus (ALV). When applied to cultured cells, the protein bridge allowed the virus not only to bind but also enter the designated cell targets. The researchers report these findings in the June 9 Proceedings of the National Academy of Sciences.

"The novel thing here is that this delivery device works efficiently, which allows for the first time the possibility that we can use this approach to target any cell type we want," says John Young, associate professor of microbiology and molecular genetics. He developed the method in collaboration with graduate student Sophie Snitkovsky.

Most efforts to design in vivo gene delivery systems have focused on further modifying the virus, for example, by building into its envelope a structure that directs the virus to a specific cell type. But the tinkering appears to interfere with the ability of the virus to enter the cells.

"We wanted to find an approach where we could preserve as much as possible the normal virus envelope -cell receptor interaction," says Young. He and Snitkovsky created the EGF-ALV receptor protein bridge and applied it to a series of cell types, including one with the normal EGF receptor and one without. Only those cells with the EGF receptor bound the molecular bridge.

To see if the virus, once linked, could actually enter cells, the researchers introduced a gene conferring resistance to the antibiotic neomycin into the viruses. They added the gene-carrying viruses to the cells and then exposed the cells to neomycin. To their surprise, the researchers saw colonies--demonstrating cells had become resistant to neomycin and thus had been infected by the virus. In fact, a much higher percentage of the cells were infected than expected. "This is really quite remarkable. I think jumping up and down is the way you?d describe our reaction," says Young.

The success may be due in part to the simplicity of the ALV system. Unlike HIV, which uses multiple receptors, ALV seems to enter cells by a single receptor. While the ALV receptor thus appears to be uniquely suited to the protein bridge approach, EGF is only one of many possible protein partners. Young and Snitkovsky speculate the method could be used on a variety of cell surface markers, including those found on cancer cells. They are currently exploring other possibilities in conjunction with graduate student Adrienne Boerger and other colleagues at Harvard Medical School. They are also working on ways to deliver the protein bridge in vivo.

"The way I look upon this experiment is that it has opened the door to the possibility of targeting by this mechanism," says Young. "It solves that problem in tissue culture. Translating that to the in vivo situation is a major hurdle now."
-end-


Harvard Medical School

Related Virus Articles from Brightsurf:

Researchers develop virus live stream to study virus infection
Researchers from the Hubrecht Institute and Utrecht University developed an advanced technique that makes it possible to monitor a virus infection live.

Will the COVID-19 virus become endemic?
A new article in the journal Science by Columbia Mailman School researchers Jeffrey Shaman and Marta Galanti explores the potential for the COVID-19 virus to become endemic, a regular feature producing recurring outbreaks in humans.

Smart virus
HSE University researchers have found microRNA molecules that are potentially capable of repressing the replication of human coronaviruses, including SARS-CoV-2.

COVID-19 - The virus and the vasculature
In severe cases of COVID-19, the infection can lead to obstruction of the blood vessels in the lung, heart and kidneys.

Lab-made virus mimics COVID-19 virus
Researchers at Washington University School of Medicine in St. Louis have created a virus in the lab that infects cells and interacts with antibodies just like the COVID-19 virus, but lacks the ability to cause severe disease.

Virus prevalence associated with habitat
Levels of virus infection in lobsters seem to be related to habitat and other species, new studies of Caribbean marine protected areas have shown.

Herpes virus decoded
The genome of the herpes simplex virus 1 was decoded using new methods.

A new biosensor for the COVID-19 virus
A team of researchers from Empa, ETH Zurich and Zurich University Hospital has succeeded in developing a novel sensor for detecting the new coronavirus.

How at risk are you of getting a virus on an airplane?
New 'CALM' model on passenger movement developed using Frontera supercomputer.

Virus multiplication in 3D
Vaccinia viruses serve as a vaccine against human smallpox and as the basis of new cancer therapies.

Read More: Virus News and Virus Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.